Medical Apartheid

Compelling, if at times gruesome, <i>Medical Apartheid</i> connects past medical experiments and the woeful current state of health care for blacks.

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Medical Apartheid: The Dark History of Medical Experimentation on Black Americans From Colonial Times to the Present
By Harriet A. Washington. Doubleday. $27.95.

In this provocatively titled book, Harriet Washington argues that the infamous “Tuskegee Experiment”—the 40-year study in which black men with syphilis were allowed to die untreated so that their cadavers could be used for research—was not an isolated incident, but rather one example of the medical establishment’s long history of mistreating African Americans. Compelling, if at times gruesome, Medical Apartheid draws a connection between past medical experiments and the woeful current state of health care for blacks.

Medical Apartheid is peppered with chilling anecdotes of racist exploitation, curiosity, and control. There is the story of John Brown, a slave purchased in Georgia in the 1820s, whose owner, a doctor, blistered his legs and arms on a daily basis to see how deep his black skin went. Far from merely cataloging horrors, Washington, a journalist and former fellow in ethics at Harvard Medical School, also illustrates what she calls the “dual face” of these abuses, pointing out that the exploitation of black subjects made numerous medical advances possible. For example, Dr. Marion Sims, a 19th-century gynecological pioneer, was only able to achieve his breakthroughs by performing horrific surgeries without anesthesia on his female slaves.

These tales are not limited to the less enlightened past. The forced sterilization of black women (what civil rights activist Fannie Lou Hamer plaintively called her “Mississippi appendectomy”) got its start during slavery, but has persisted in less overt forms in recent years. A 1991 experiment that implanted the now-defunct birth control device Norplant into African American teenagers in Baltimore was applauded by some observers as a way to “reduce the underclass.” Washington also finds that racist assumptions still creep into high-level medical research. A 1992 Columbia University study looking for a genetic link to violent behavior only recruited young black boys from poor neighborhoods in New York City. Researchers misled the parents, claiming their children were simply coming in for a series of tests and questions, when in fact they were given potentially risky doses of the same drug found in the Fen-Pfen weight loss pill.

One of the most harmful contemporary legacies of this history of abusive medical experimentation is that many African Americans are wary of participating in potentially life saving medical studies. A recent study in the American Journal of Law and Medicine estimated that only 1 percent of the nearly 20 million Americans enrolled in biomedical studies are black. This reluctance, though justified, has meant that blacks often miss out on the latest treatments and breakthroughs. In the 1980s, for instance, virtually no African Americans were used in trials of the HIV inhibitor AZT. When the drug came into widespread use in 1991, the Food and Drug Administration had scant research on blacks and erroneously reported that it was not effective for black patients. If more blacks had been included in the original studies, Washington wonders, “would the number of HIV-infected African Americans be lower today?”

Washington’s book is a rallying call for change within the medical and African American communities. While doctors must understand their black patients’ fears of exploitation, African Americans, Washington writes, “cannot afford passivity.” Increased participation in ethically designed medical studies would not only be a boon to African Americans suffering from serious diseases but would also lead to better preventive care in general. As she concludes, “Physicians, patients, and ethicists must…understand that acknowledging abuse and encouraging African Americans to participate in medical research are compatible goals.”


If you buy a book using a Bookshop link on this page, a small share of the proceeds supports our journalism.

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

WE'LL BE BLUNT.

We have a considerable $390,000 gap in our online fundraising budget that we have to close by June 30. There is no wiggle room, we've already cut everything we can, and we urgently need more readers to pitch in—especially from this specific blurb you're reading right now.

We'll also be quite transparent and level-headed with you about this.

In "News Never Pays," our fearless CEO, Monika Bauerlein, connects the dots on several concerning media trends that, taken together, expose the fallacy behind the tragic state of journalism right now: That the marketplace will take care of providing the free and independent press citizens in a democracy need, and the Next New Thing to invest millions in will fix the problem. Bottom line: Journalism that serves the people needs the support of the people. That's the Next New Thing.

And it's what MoJo and our community of readers have been doing for 47 years now.

But staying afloat is harder than ever.

In "This Is Not a Crisis. It's The New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, why this moment is particularly urgent, and how we can best communicate that without screaming OMG PLEASE HELP over and over. We also touch on our history and how our nonprofit model makes Mother Jones different than most of the news out there: Letting us go deep, focus on underreported beats, and bring unique perspectives to the day's news.

You're here for reporting like that, not fundraising, but one cannot exist without the other, and it's vitally important that we hit our intimidating $390,000 number in online donations by June 30.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. It's going to be a nail-biter, and we really need to see donations from this specific ask coming in strong if we're going to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate